262 related articles for article (PubMed ID: 36352420)
21. Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.
Zou R; Jiang Q; Jin T; Chen M; Yao L; Ding H
Front Immunol; 2022; 13():956224. PubMed ID: 36032075
[TBL] [Abstract][Full Text] [Related]
22. Biological characteristics and genetic heterogeneity between carcinoma-associated fibroblasts and their paired normal fibroblasts in human breast cancer.
Peng Q; Zhao L; Hou Y; Sun Y; Wang L; Luo H; Peng H; Liu M
PLoS One; 2013; 8(4):e60321. PubMed ID: 23577100
[TBL] [Abstract][Full Text] [Related]
23. Integrative Analysis From Multicenter Studies Identifies a WGCNA-Derived Cancer-Associated Fibroblast Signature for Ovarian Cancer.
Feng S; Xu Y; Dai Z; Yin H; Zhang K; Shen Y
Front Immunol; 2022; 13():951582. PubMed ID: 35874760
[TBL] [Abstract][Full Text] [Related]
24. Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors.
Erez N; Glanz S; Raz Y; Avivi C; Barshack I
Biochem Biophys Res Commun; 2013 Aug; 437(3):397-402. PubMed ID: 23831470
[TBL] [Abstract][Full Text] [Related]
25. CAF-derived HGF promotes cell proliferation and drug resistance by up-regulating the c-Met/PI3K/Akt and GRP78 signalling in ovarian cancer cells.
Deying W; Feng G; Shumei L; Hui Z; Ming L; Hongqing W
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28258248
[TBL] [Abstract][Full Text] [Related]
26. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
[TBL] [Abstract][Full Text] [Related]
27. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer.
Rynne-Vidal A; Au-Yeung CL; Jiménez-Heffernan JA; Pérez-Lozano ML; Cremades-Jimeno L; Bárcena C; Cristóbal-García I; Fernández-Chacón C; Yeung TL; Mok SC; Sandoval P; López-Cabrera M
J Pathol; 2017 Jun; 242(2):140-151. PubMed ID: 28247413
[TBL] [Abstract][Full Text] [Related]
28. NPPB is a novel candidate biomarker expressed by cancer-associated fibroblasts in epithelial ovarian cancer.
Lawrenson K; Grun B; Lee N; Mhawech-Fauceglia P; Kan J; Swenson S; Lin YG; Pejovic T; Millstein J; Gayther SA
Int J Cancer; 2015 Mar; 136(6):1390-401. PubMed ID: 25047817
[TBL] [Abstract][Full Text] [Related]
29. CAF-Associated Paracrine Signaling Worsens Outcome and Potentially Contributes to Chemoresistance in Epithelial Ovarian Cancer.
Wessolly M; Mairinger E; Borchert S; Bankfalvi A; Mach P; Schmid KW; Kimmig R; Buderath P; Mairinger FD
Front Oncol; 2022; 12():798680. PubMed ID: 35311102
[TBL] [Abstract][Full Text] [Related]
30. GLIS1 in Cancer-Associated Fibroblasts Regulates the Migration and Invasion of Ovarian Cancer Cells.
Kim MJ; Jung D; Park JY; Lee SM; An HJ
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216340
[TBL] [Abstract][Full Text] [Related]
31. Tumour microenvironment-based molecular profiling reveals ideal candidates for high-grade serous ovarian cancer immunotherapy.
Lu X; Ji C; Jiang L; Zhu Y; Zhou Y; Meng J; Gao J; Lu T; Ye J; Yan F
Cell Prolif; 2021 Mar; 54(3):e12979. PubMed ID: 33522069
[TBL] [Abstract][Full Text] [Related]
32. Deciphering the immune landscape dominated by cancer-associated fibroblasts to investigate their potential in indicating prognosis and guiding therapeutic regimens in high grade serous ovarian carcinoma.
Li Y; Tian R; Liu J; Li J; Tan H; Wu Q; Fu X
Front Immunol; 2022; 13():940801. PubMed ID: 36119108
[TBL] [Abstract][Full Text] [Related]
33. Analysis of cancer-associated fibroblasts in cervical cancer by single-cell RNA sequencing.
Wen S; Lv X; Li P; Li J; Qin D
Aging (Albany NY); 2023 Dec; 15(24):15340-15359. PubMed ID: 38157264
[TBL] [Abstract][Full Text] [Related]
34. Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.
Wintzell M; Hjerpe E; Åvall Lundqvist E; Shoshan M
BMC Cancer; 2012 Aug; 12():359. PubMed ID: 22901285
[TBL] [Abstract][Full Text] [Related]
35. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer.
Peng Z; Ye M; Ding H; Feng Z; Hu K
J Transl Med; 2022 Jul; 20(1):302. PubMed ID: 35794563
[TBL] [Abstract][Full Text] [Related]
36. Integrative analysis deciphers the heterogeneity of cancer-associated fibroblast and implications on clinical outcomes in ovarian cancers.
Zhao Y; Mei S; Huang Y; Chen J; Zhang X; Zhang P
Comput Struct Biotechnol J; 2022; 20():6403-6411. PubMed ID: 36420154
[TBL] [Abstract][Full Text] [Related]
37. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway.
Zhang S; Leng T; Zhang Q; Zhao Q; Nie X; Yang L
Biomed Pharmacother; 2018 Jun; 102():302-308. PubMed ID: 29571014
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts.
Schauer IG; Zhang J; Xing Z; Guo X; Mercado-Uribe I; Sood AK; Huang P; Liu J
Neoplasia; 2013 Apr; 15(4):409-20. PubMed ID: 23555186
[TBL] [Abstract][Full Text] [Related]
39. Stromal-epithelial crosstalk provides a suitable microenvironment for the progression of ovarian cancer cells in vitro.
Fu S; Dong L; Sun W; Xu Y; Gao L; Miao Y
Cancer Invest; 2013 Nov; 31(9):616-24. PubMed ID: 24147897
[TBL] [Abstract][Full Text] [Related]
40. CAFs-derived MFAP5 promotes bladder cancer malignant behavior through NOTCH2/HEY1 signaling.
Zhou Z; Cui D; Sun MH; Huang JL; Deng Z; Han BM; Sun XW; Xia SJ; Sun F; Shi F
FASEB J; 2020 Jun; 34(6):7970-7988. PubMed ID: 32293074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
